135015-78-0

Basic information

• Product Name: Quinoline, 2-ethyl-7-methoxy-4-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methoxy]-, monohydrochloride
• CAS NO: 135015-78-0
• Molecular Formula: C26H23N5O2.ClH
• Molecular Weight: 473.962
• Mol File: 135015-78-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Quinoline, 2-ethyl-7-methoxy-4-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methoxy]-, monohydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Quinoline, 2-ethyl-7-methoxy-4-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methoxy]-, monohydrochloride(135015-78-0)
• EPA Substance Registry System: Quinoline, 2-ethyl-7-methoxy-4-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methoxy]-, monohydrochloride(135015-78-0)

Safety Data

• Hazardous Substances Data: 135015-78-0(Hazardous Substances Data)

Upstream product

• 30414-53-0 methyl propanoyl acetate 
• 536-90-3 m-Anisidine 
• 124750-51-2 N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole 

Relevant articles and documents

QUINOLINE DERIVATIVES AND USE THEREOF AS ANGIOTENSIN II ANTAGONISTS

The invention concerns pharmaceutically useful novel compounds of the formula I, in which R 1, R 2, R 3, R 4, R 5, Ra, A, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment. STR1